Purity vs Potency: The Difference on a Retatrutide Listing
Purity and potency measure different things on a retatrutide listing. Learn how each figure is tested, what it tells you, and why both matter.
Anika Patel, MD, MPH is a board-certified physician with a Master of Public Health from Harvard T.H. Chan School of Public Health whose research bridges internal medicine, obesity medicine, and the public health implications of novel peptide therapeutics.
The difference between purity and potency claims on a retatrutide listing comes down to what each number actually measures. Purity describes how much of the material in a vial is the intended peptide versus contaminants or breakdown products. Potency, sometimes labeled as content or assay value, describes how much of that peptide is actually present relative to what the label states. A listing can report high purity and still fall short on labeled amount, and the reverse is also possible. Reading both figures together, rather than treating either one as a stand-in for overall quality, is the only way to interpret a certificate of analysis (COA) correctly.
What Purity Actually Measures
Purity is typically generated through high-performance liquid chromatography (HPLC). The lab separates the components of a sample and measures the area of each peak on the resulting chromatogram. The peak matching the target peptide’s expected retention time is compared to the total area of all peaks, including any related impurities, truncated sequences, or degradation products. The result is expressed as a percentage, such as 98% or 99%.
A high purity percentage tells you that most of what’s dissolved in the solution is the intended peptide rather than synthesis byproducts. It does not tell you how much total peptide mass is in the vial. A vial could report 99% purity on a sample that actually contains far less total peptide than the label claims, because purity is a ratio among what’s present, not a measurement of total quantity.
What Potency Actually Measures
Potency, or content assay, addresses the question purity leaves open: how much peptide is in the vial relative to the labeled amount. This is usually calculated by comparing the mass of peptide detected in a reference standard curve against the vial’s stated milligram content. A vial labeled at 10 mg that assays at 9.5 mg of actual peptide would report a potency figure of 95%.
This number matters because underfilled or under-synthesized vials can still show clean purity results. The chromatogram only evaluates the relative composition of what was tested, so a vial with less total peptide than labeled can still produce a “clean” peak profile if the impurity ratio happens to be low. Potency closes that gap by anchoring the result to an absolute reference rather than a relative one.
Why Listings Separate the Two Figures
A complete COA reports purity and potency as distinct line items, sometimes alongside a separate identity test (typically mass spectrometry) that confirms the molecule detected actually matches retatrutide’s expected structure rather than a similar-looking compound. Treating any single figure as a complete quality summary misses information the other two provide. Buyers evaluating a listing benefit from checking that all three are present and dated, rather than assuming one implies the others.
| Metric | What it measures | Typical method | What it does not tell you |
|---|---|---|---|
| Purity | Ratio of target peptide to total detected material | HPLC | Total quantity of peptide in the vial |
| Potency (content assay) | Actual mass versus labeled mass | Mass comparison against reference standard | Whether detected impurities are structurally similar or unrelated |
| Identity | Whether the detected molecule matches the expected structure | Mass spectrometry | Purity or potency values on their own |
How the Two Figures Interact on a Real Listing
Consider a hypothetical vial labeled 10 mg. If the COA lists 98% purity and 95% potency, that means roughly 98% of the material detected during the chromatography run corresponds to the target peptide, and separately, the assayed total mass came out to about 9.5 mg against the 10 mg label. These are two independent calculations pulled from different parts of the same testing process, not a single score split into halves. A listing that only publishes one of the two figures is giving buyers half the picture, regardless of how favorable that one figure looks.
Some listings round or omit potency because it is more sensitive to handling, storage temperature, and time since manufacture than purity is. A vial can lose potency over time through degradation even while the purity of what remains stays relatively stable, since certain degradation pathways affect concentration more than composition ratio. This is one reason test dates on a COA are as relevant as the numbers themselves.
Reading a Listing With Both Numbers in Mind
When comparing retatrutide listings, look for whether the seller publishes a COA with a visible test date, lab name, and both purity and potency values rather than a single blended “quality” percentage. A listing that discloses methodology, such as naming HPLC for purity and stating how the content assay was calculated, is generally more transparent than one that states a bare percentage without context. Buyers researching sourcing options sometimes cross-reference a COA-verified source to see how a fuller documentation set is typically presented, which makes it easier to spot listings that are missing pieces.
It also helps to compare how consistently a seller’s listings report both figures across their catalog. A single well-documented product page can be an exception rather than the norm, so checking whether the pattern holds across multiple listings from the same source gives a better sense of their general testing and disclosure practices. Community-maintained directories such as Reta Info sometimes compile notes on which sources consistently publish complete documentation, which can be a useful starting point before evaluating a specific listing in detail.
Summary
Purity and potency answer different questions on a retatrutide listing. Purity reflects the ratio of target peptide to everything else detected in a sample, typically via HPLC. Potency reflects how much total peptide mass is present relative to the label, typically via a content assay against a reference standard. Neither figure substitutes for the other, and a complete listing discloses both, along with an identity check and a test date, so buyers can evaluate composition and quantity as the separate measurements they actually are.